CABOSEQ: The efficacy of cabozantinib post up-front immuno-oncology combinations in patients with advanced renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).Vishal Navani, Daniel Yick Chin Heng, Devon J. Boyne et al.|Journal of Clinical Oncology|2022Cited by 5